SERES Posts Robust H1 2025 Results: Revenue Hits CNY 62.4 Billion, Net Profit Up 81% to CNY 2.94 Billion, R&D Investment Soars nearly 155%

10 months ago

CHONGQING, China, Sept. 3, 2025 /PRNewswire/ -- On August 29, SERES announced its 2025 mid-year results, reporting strong growth across all…

Coventry and Alan Buerger Move to Dismiss Abacus Lawsuit

10 months ago

Motion underscores that Abacus's claims lack merit as Lapetus, its key life expectancy provider, shut its doors August 31 FORT…

Coming Soon | GAC Will Officially Showcase Global Strategic Models at IAA Mobility 2025 in Munich

10 months ago

MUNICH, Sept. 3, 2025 /PRNewswire/ -- As one of the world's top five automotive exhibitions, IAA Mobility 2025 will officially…

TACC and CGT Unite to Drive Graphene Revolution

10 months ago

NEW DELHI, Sept. 2, 2025 /PRNewswire/ -- TACC Limited, a wholly owned subsidiary of HEG Limited and part of the…

ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones

10 months ago

ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS from Sept. 12 - 15 in Copenhagen,…

Herbalife India Honored with ‘Sustainable Supply Chain Award’ at BIGBOX India 2025

10 months ago

BENGALURU, India, Sept. 2, 2025 /PRNewswire/ -- Herbalife India, a premier health and wellness company, community, and platform, proudly announces…

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

10 months ago

September 02, 2025 21:33 ET  | Source: Mineralys Therapeutics, Inc. RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics,…

Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI IQLIK(lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease Under Fast Track Status

10 months ago

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from…

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 months ago

September 02, 2025 17:00 ET  | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc.…

How Sparkvia AI Website Tool Proves Real AI Utility on XRP SPARK Public Sale is Open for Early Investors

10 months ago

VALLETTA, Malta, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sparkvia AI has officially opened the public sale of its utility token,…